Epstein-barr virus provides a new paradigm: A requirement for the immediate inhibition of apoptosis

PLoS Biology

Volumn 3, Issue 12, 2005, Pages 1-10

  Altmann, Markus ^a   Hammerschmidt, Wolfgang ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; BALF1 PROTEIN, EPSTEIN BARR VIRUS; BALF1 PROTEIN, EPSTEIN-BARR VIRUS; BHRF1 PROTEIN, HUMAN HERPESVIRUS 4; MESSENGER RNA; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL ACTIVATION; CELL CYCLE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA VIRUS; EPSTEIN BARR VIRUS; GENE EXPRESSION; HOST CELL; HUMAN; HUMAN CELL; MEMORY CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; SEQUENCE HOMOLOGY; B LYMPHOCYTE; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

CANCER VIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 4;

APOPTOSIS; B-LYMPHOCYTES; BASE SEQUENCE; CELLS, CULTURED; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; VIRAL PROTEINS;

EID: 29144463656     PISSN: 15457885     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.0030404     Document Type: Article

References (62)

1. Cuconati A, White E (2002) Viral homologs of BCL-2: Role of apoptosis in the regulation of virus infection. Genes Dev 16: 2465-2478.
2. Boya P, Pauleau AL, Poncet D, Gonzalez-Polo RA, Zamzami N, et al. (2004) Viral proteins targeting mitochondria: Controlling cell death. Biochim Biophys Acta 1659: 178-189.
3. Benedict CA, Norris PS, Ware CF (2002) To kill or be killed: Viral evasion of apoptosis. Nat Immunol 3: 1013-1018.
4. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, et al. (1993) Epstein-Barr virus-coded BHRF1 protein: A viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci U S A 90:8479-8483.
5. Bellows DS, Howell M, Pearson C, Hazlewood SA, Hardwick JM (2002) Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins. J Virol 76: 2469-2479.
6. Marshall WL, Yim C, Gustafson E, Graf T, Sage DR, et al. (1999) Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. J Virol 73: 5181-5185.
7. Irusta PM, Chen YB, Hardwick JM (2003) Viral modulators of cell death provide new links to old pathways. Curr Opin Cell Biol 15: 700-705.
8. Hilleman MR (2004) Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections. Proc Natl Acad Sci U S A 101: 14560-14566.
9. Roulston A, Marcellus RC, Branton PE (1999) Viruses and apoptosis. Annu Rev Microbiol 53: 577-628.
10. de Lima BD, May JS, Marques S, Simas JP, Stevenson PG (2005) Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo. J Gen Virol 86: 31-40.
11. Gangappa S, Kapadia SB, Speck SH, Virgin HW (2002) Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J Virol 76: 11460-11468.
12. Gangappa S, van Dyk LF, Jewett TJ, Speck SH, Virgin HW (2002) Identification of the in vivo role of a viral bcl-2. J Exp Med 195: 931-940.
13. Küppers R (2003) B cells under influence: Transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 3: 801-812.
14. Babcock GJ, Hochberg D, Thorley-Lawson AD (2000) The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13: 497-506.
15. Kieff E, Rickinson AB (2001) Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, Grif.n DE, Martin MA, Lamb RA, et al., editors. Fields' virology, 4th ed. Philadelphia: Lippincott-Williams and Wilkins. pp. 2511-2573.
16. Rickinson AB, Kieff E (2001) Epstein-Barr virus. In: Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, et al., editors. Fields' virology, 4th ed. Philadelphia: Lippincott-Williams and Wilkins. pp. 2575-2627.
17. [Anonymous] (1997) Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8; International Agency for Research on Cancer. Lyon (France): IARC.
18. Dirmeier U, Hoffmann R, Kilger E, Schultheiss U, Briseno C, et al. (2005) Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24: 1711-1717.
19. Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J, Kieff E (2000) NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virustransformed lymphoblastoid cells. Proc Natl Acad Sci U S A 97: 6055-6060.
20. Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, et al. (2004) Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. J Virol 78: 4108-4119.
21. Feuillard J, Schuhmacher M, Kohanna S, Asso-Bonnet M, Ledeur F, et al. (2000) Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. Blood 95: 2068-2075.
22. Kilger E, Kieser A, Baumann M, Hammerschmidt W (1998) Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J 17: 1700-1709.
23. Kulwichit W, Edwards RH, Davenport EM, Baskar JF, Godfrey V, et al. (1998) Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci U S A 95:11963-11968.
24. Hammerschmidt W, Sugden B (1989) Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340: 393-397.
25. Cohen JI, Wang F, Mannick J, Kieff E (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci U S A 86: 9558-9562.
26. Kaye KM, Izumi KM, Kieff E (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci U S A 90: 9150-9154.
27. Tomkinson B, Robertson E, Kieff E (1993) Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 67: 2014-2025.
28. Kempkes B, Pich D, Zeidler R, Sugden B, Hammerschmidt W (1995) Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA. J Virol 69: 231-238.
29. Dirmeier U, Neuhierl B, Kilger E, Reisbach G, Sandberg ML, et al. (2003) Latent membrane protein 1 is critical for efficient growth transformation of human B cells by Epstein-Barr virus. Cancer Res 63: 2982-2989.
30. Humme S, Reisbach G, Feederle R, Delecluse HJ, Bousset K, et al. (2003) The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc Natl Acad Sci U S A 100: 10989-10994.
31. Neuhierl B, Feederle R, Hammerschmidt W, Delecluse HJ (2002) Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection. Proc Natl Acad Sci U S A 99: 15036-15041.
32. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W (1998) Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95: 8245-8250.
33. Frisan T, Levitsky V, Masucci M (2001) Limiting dilution assay. Methods Mol Biol 174: 213-216.
34. Garrone P, Neidhardt EM, Garcia E, Galibert L, van Kooten C, et al. (1995) Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 182: 1265-1273.
35. Zarnegar B, He JQ, Oganesyan G, Hoffmann A, Baltimore D, et al. (2004) Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. Proc Natl Acad Sci U S A 101: 8108-8113.
36. Pearson GR, Luka J, Petti L, Sample J, Birkenbach M, et al. (1987) Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160: 151-161.
37. Kempkes B, Spitkovsky D, Jansen-Durr P, Ellwart JW, Kremmer E, et al. (1995) B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J 14: 88-96.
38. Schepers A, Pich D, Hammerschmidt W (1996) Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1. Virology 220: 367-376.
39. Feederle R, Kost M, Baumann M, Janz A, Drouet E, et al. (2000) The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19: 3080-3089.
40. Sinclair A, Palmero I, Peters G, Farrell PJ (1994) EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J 13: 3321-3328.
41. Hardwick JM, Bellows DS (2003) Viral versus cellular BCL-2 proteins. Cell Death Differ 10: S68-S76.
42. Shen Y, Shenk TE (1995) Viruses and apoptosis. Curr Opin Genet Dev 5: 105-111.
43. Marchini A, Tomkinson B, Cohen JI, Kieff E (1991) BHRF1, the Epstein-Barr virus gene with homology to Bcl2, is dispensable for B-lymphocyte transformation and virus replication. J Virol 65: 5991-6000.
44. Lee MA, Yates JL (1992) BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of B cells or for virus replication in vitro. J Virol 66: 1899-1906.
45. Foghsgaard L, Jaattela M (1997) The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type. J Virol 71: 7509-7517.
46. Murray PG, Swinnen LJ, Constandinou CM, Pyle JM, Carr TJ, et al. (1996) BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders. Blood 87: 706-711.
47. Flano E, Kim IJ, Woodland DL, Blackman MA (2002) Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med 196: 1363-1372.
48. Willer DO, Speck SH (2003) Long-term latent murine Gamma-herpesvirus 68 infection is preferentially found within the surface immunoglobulin Dnegative subset of splenic B cells in vivo. J Virol 77: 8310-8321.
49. Gibson W, Roizman B (1971) Compartmentalization of spermine and spermidine in the herpes simplex virion. Proc Natl Acad Sci U S A 68: 2818-2821.
50. Booy FP, Newcomb WW, Trus BL, Brown JC, Baker TS, et al. (1991) Liquidcrystalline, phage-like packing of encapsidated DNA in herpes simplex virus. Cell 64: 1007-1015.
51. Thorley-Lawson DA (2001) Epstein-Barr virus: Exploiting the immune system. Nat Rev Immunol 1: 75-82.
52. Thorley-Lawson DA, Babcock GJ (1999) A model for persistent infection with Epstein-Barr virus: The stealth virus of human B cells. Life Sci 65: 1433-1453.
53. Küppers R (2002) Molecular biology of Hodgkin's lymphoma. Adv Cancer Res 84: 277-312.
54. Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, et al. (1989) Mechanism of antigen-driven selection in germinal centres. Nature 342: 929-931.
55. Caldwell RG, Wilson JB, Anderson SJ, Longnecker R (1998) Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9: 405-411.
56. Mancao C, Altmann M, Jungnickel B, Hammerschmidt W (2005) Rescue of 'crippled' germinal center B cells from apoptosis by Epstein-Barr virus. Blood. E-pub ahead of print.
57. Neuhierl B, Delecluse HJ (2005) Molecular genetics of DNA viruses: Recombinant virus technology. Methods Mol Biol 292: 353-370.
58. Cherepanov PP, Wackernagel W (1995) Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158: 9-14.
59. Posfai G, Koob MD, Kirkpatrick HA, Blattner FR (1997) Versatile insertion plasmids for targeted genome manipulations in bacteria: Isolation, deletion, and rescue of the pathogenicity island LEE of the Escherichia coli O157:H7 genome. J Bacteriol 179: 4426-4428.
60. O'Connor M, Peifer M, Bender W (1989) Construction of large DNA segments in Escherichia coli. Science 244: 1307-1312.
61. Hammerschmidt W, Sugden B (1988) Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55: 427-433.
62. Takada K, Horinouchi K, Ono Y, Aya T, Osato T, et al. (1991) An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA. Virus Genes 5: 147-156.